6801 - 6825 of 7730 Results
Title
Year
-
RESTRICTEDTitle: Concomitant pathologies among a spectrum of parkinsonian disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 525End Page: 529Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012Best OA location URL: https://europepmc.org/articles/pmc4028418?pdf=renderCitation Count: 109
- Concordance and Discriminatory Power of Cough Measurement Devices for Individuals With Parkinson Disease2014RESTRICTEDTitle: Concordance and Discriminatory Power of Cough Measurement Devices for Individuals With Parkinson DiseaseJournal Name: ChestPublisher: Elsevier BVVol: 145Issue #: 5Start Page: 1089End Page: 1096Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1378/chest.13-0596Best OA location URL: https://europepmc.org/articles/pmc4011653?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: Dysregulation of glucose metabolism is an early event in sporadic Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 5Start Page: 1111End Page: 1115Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.11.001Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2013.11.001Citation Count: 179
-
RESTRICTEDTitle: Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's diseaseJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 83Issue #:Start Page: 20End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2014.02.005Best OA location URL: https://europepmc.org/articles/pmc6075820?pdf=renderCitation Count: 54
- The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal Dysfunction2014RESTRICTEDTitle: The Thorny Problem of Dyskinesias: Dendritic Spines, Synaptic Plasticity, and Striatal DysfunctionJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 75Issue #: 9Start Page: 676End Page: 677Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2014.02.019Best OA location URL: https://europepmc.org/articles/pmc4120525?pdf=renderCitation Count: 1
-
RESTRICTEDTitle: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 460Issue #: 1Start Page: 127End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20140334Best OA location URL: https://portlandpress.com/biochemj/article-pdf/460/1/127/678769/bj4600127.pdfCitation Count: 679
-
RESTRICTEDTitle: High-throughput neuroimaging-genetics computational infrastructureJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2014.00041Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2014.00041/pdfCitation Count: 27
-
RESTRICTEDTitle: Barriers to investigator-initiated deep brain stimulation and device researchJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 16Start Page: 1465End Page: 1473Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000345Best OA location URL: https://europepmc.org/articles/pmc4001198?pdf=renderCitation Count: 16
- Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP12014RESTRICTEDTitle: Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 18Start Page: 6804End Page: 6809Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1321845111Best OA location URL: https://www.pnas.org/content/pnas/111/18/6804.full.pdfCitation Count: 183
-
RESTRICTEDTitle: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ncomms4633Best OA location URL: https://www.nature.com/articles/ncomms4633.pdfCitation Count: 263
-
RESTRICTEDTitle: Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 17Start Page: 4621End Page: 4638Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddu178Best OA location URL: https://academic.oup.com/hmg/article-pdf/23/17/4621/2215861/ddu178.pdfCitation Count: 132
-
RESTRICTEDTitle: The neurobiological basis of cognitive impairment in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 5Start Page: 634End Page: 650Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25857Best OA location URL: https://europepmc.org/articles/pmc4049032?pdf=renderCitation Count: 300
- Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus Accumbens2014RESTRICTEDTitle: Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus AccumbensJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 4Start Page: e94771End Page: e94771Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0094771Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094771&type=printableCitation Count: 127
- Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice2014RESTRICTEDTitle: Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic MiceJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 4Start Page: e94826End Page: e94826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0094826Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094826&type=printableCitation Count: 25
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents2014RESTRICTEDTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page: 2465End Page: 2480Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cne.23583Best OA location URL: https://europepmc.org/articles/pmc4076169?pdf=renderCitation Count: 114
-
RESTRICTEDTitle: Resistance of naturally secreted α‐synuclein to proteolysisJournal Name: The FASEB JournalPublisher: WileyVol: 28Issue #: 7Start Page: 3146End Page: 3158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.13-245852Citation Count: 19
-
RESTRICTEDTitle: Essential Tremor in the Elderly and Risk for DementiaJournal Name: Journal of Neurodegenerative DiseasesPublisher: Hindawi LimitedVol: 2014Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/328765Best OA location URL: https://downloads.hindawi.com/archive/2014/328765.pdfCitation Count: 20
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 2
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p4.043Citation Count: 2
-
RESTRICTEDTitle: Evaluation of mild cognitive impairment subtypes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 756End Page: 764Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25875Best OA location URL: https://europepmc.org/articles/pmc4013249?pdf=renderCitation Count: 54
-
RESTRICTEDTitle: Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?Journal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 12Start Page: 2802End Page: 2816Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cne.23577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cne.23577Citation Count: 46
- Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits2014RESTRICTEDTitle: Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficitsJournal Name: Frontiers in Systems NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsys.2014.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsys.2014.00045/pdfCitation Count: 85
- Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s2014RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1